ASX - By Stock
|
IVZ |
Re:
IVZ media thread
|
|
pachinko
|
6.8K |
2.4M |
7 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
6.8K
|
2.4M
|
7
|
|
ASX - By Stock
|
HIO |
Re:
Top 20 Shareholders
|
|
pachinko
|
855 |
432K |
13 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
855
|
432K
|
13
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Reports Record QVC Sales
|
|
pachinko
|
111 |
25K |
2 |
26/06/21 |
26/06/21 |
ASX - By Stock
|
111
|
25K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
An Evaluation of CDY Going Forward
|
|
pachinko
|
120 |
26K |
8 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
120
|
26K
|
8
|
|
ASX - By Stock
|
9SP |
Re:
9SP General Discussion
|
|
pachinko
|
720 |
189K |
1 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
720
|
189K
|
1
|
|
ASX - By Stock
|
9SP |
Re:
9SP General Discussion
|
|
pachinko
|
720 |
189K |
1 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
720
|
189K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
An Evaluation of CDY Going Forward
|
|
pachinko
|
120 |
26K |
0 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
120
|
26K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp appoints VP, Commercial to progress growth strategy
|
|
pachinko
|
231 |
80K |
2 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
231
|
80K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp appoints VP, Commercial to progress growth strategy
|
|
pachinko
|
231 |
80K |
0 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
231
|
80K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Rights Issue Closed with Strong Demand
|
|
pachinko
|
154 |
28K |
1 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
154
|
28K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Rights Issue Closed with Strong Demand
|
|
pachinko
|
154 |
28K |
0 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
154
|
28K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Rights Issue Closed with Strong Demand
|
|
pachinko
|
154 |
28K |
2 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
154
|
28K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Rights Issue Closed with Strong Demand
|
|
pachinko
|
154 |
28K |
2 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
154
|
28K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Rights Issue Closed with Strong Demand
|
|
pachinko
|
154 |
28K |
3 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
154
|
28K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Proposed issue of Securities - CDY
|
|
pachinko
|
2 |
915 |
0 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
2
|
915
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Rights Issue Closed with Strong Demand
|
|
pachinko
|
154 |
28K |
0 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
154
|
28K
|
0
|
|
ASX - By Stock
|
9SP |
Re:
9SP Future potential
|
|
pachinko
|
294 |
75K |
3 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
294
|
75K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4D and Half Year Report
|
|
pachinko
|
48 |
8.4K |
4 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
48
|
8.4K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Receives First Order From Chinese Distributor
|
|
pachinko
|
50 |
12K |
2 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
50
|
12K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
China Market …….. HUGE !
|
|
pachinko
|
23 |
6.9K |
2 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
23
|
6.9K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: FY20 Results Presentation
|
|
pachinko
|
52 |
9.8K |
2 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
52
|
9.8K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Share Placement Raises $6 Million
|
|
pachinko
|
128 |
39K |
3 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
128
|
39K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Reports on Results of The Doherty Institute Testing
|
|
pachinko
|
113 |
29K |
1 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
113
|
29K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice - Halasz
|
|
pachinko
|
15 |
4.8K |
0 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
15
|
4.8K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice - Halasz
|
|
pachinko
|
15 |
4.8K |
0 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
15
|
4.8K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Kaiser Permanente
|
|
pachinko
|
71 |
14K |
0 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
71
|
14K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Kaiser Permanente
|
|
pachinko
|
71 |
14K |
0 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
71
|
14K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Reports on Strong QVC Sales Event
|
|
pachinko
|
33 |
6.8K |
2 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
33
|
6.8K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Reports on Strong QVC Sales Event
|
|
pachinko
|
33 |
6.8K |
1 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
33
|
6.8K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Reports on Strong QVC Sales Event
|
|
pachinko
|
33 |
6.8K |
6 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
33
|
6.8K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Reports on Results of The Doherty Institute Testing
|
|
pachinko
|
113 |
29K |
3 |
15/06/20 |
15/06/20 |
ASX - By Stock
|
113
|
29K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
pachinko
|
162 |
48K |
2 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
162
|
48K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Company Update
|
|
pachinko
|
149 |
38K |
0 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
149
|
38K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Company Update
|
|
pachinko
|
149 |
38K |
2 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
149
|
38K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
pachinko
|
162 |
48K |
1 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
162
|
48K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
pachinko
|
162 |
48K |
1 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
162
|
48K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
pachinko
|
162 |
48K |
3 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
162
|
48K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
pachinko
|
1.2K |
409K |
5 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
pachinko
|
1.2K |
409K |
2 |
10/05/20 |
10/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
pachinko
|
79 |
25K |
1 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
79
|
25K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
pachinko
|
1.2K |
409K |
2 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
pachinko
|
1.2K |
409K |
0 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
pachinko
|
1.2K |
409K |
3 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
50% margin ? The product
|
|
pachinko
|
83 |
34K |
0 |
23/04/20 |
23/04/20 |
ASX - By Stock
|
83
|
34K
|
0
|
|
ASX - By Stock
|
AN1 |
9 days to go Maria
|
|
pachinko
|
15 |
5.7K |
0 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
15
|
5.7K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
pachinko
|
394 |
122K |
0 |
18/04/20 |
18/04/20 |
ASX - By Stock
|
394
|
122K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
pachinko
|
394 |
122K |
1 |
18/04/20 |
18/04/20 |
ASX - By Stock
|
394
|
122K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Proposed issue of Securities - CDY
|
|
pachinko
|
56 |
13K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
56
|
13K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
pachinko
|
394 |
122K |
5 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
122K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
pachinko
|
394 |
122K |
0 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
394
|
122K
|
0
|
|